Company intelligence / Profile preview

Minakem

Beuvry-la-forêt, Hauts-de-France, Franceminakem.com ↗

Ownership: Private
Employees: ~394
Development stage: Other

Overview

Minakem does not have its own clinical pipeline or results. It provides cGMP manufacturing and development services for small molecule APIs—including highly potent compounds—for global pharmaceutical clients at all stages from preclinical to commercial supply. The company’s expertise includes complex multi-step synthesis, chiral chemistry, steroid chemistry, halogenation chemistry, pressure chemistry and more. Facilities are FDA-inspected and support both innovators’ and generics’ products. Recent expansions include high-potency API capabilities in Belgium and North America.

Modalities: Small moleculeSteroidHighly potent active pharmaceutical ingredient (HPAPI)Fine chemicalsIntermediates
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Minakem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Minakem.

Explore the full profile